Dementia Archives

Life Science Spotlight

In Alzheimer’s Dementia, Should EEG Be Used as a Functional Biomarker of Target Engagement and Organizational Change When Evaluating Treatment Efficacy?

April 11, 2024

Life Science Spotlight

How Are Blood-Based Biomarkers Reshaping Alzheimer’s Disease Diagnostics and Treatment?

March 28, 2024

Blogs

Brain Awareness Week 2024: A Spotlight on Brain Health and New Treatments for Neurological Diseases

March 6, 2024

Biotech News

Biogen Shelves Contentious Alzheimer’s Drug Aduhelm

February 29, 2024

Approvals News

BrainSee AI-Powered Dementia Test Receives FDA Approval

January 17, 2024

Blogs

Cognitive and Neuropsychiatric Disorders Drug Development, Featuring Dr. Adam Kaplin, Cofounder, President, CSO, MIRA Pharmaceuticals – Xtalks Life Science Podcast Ep. 141

January 10, 2024

Blogs

Insights into New Alzheimer’s Treatments: Treating Agitation and First THC-Based Therapeutic in Trials — Interview with IGC’s Ram Mukunda and Claudia Grimaldi – Xtalks Life Science Podcast Ep. 127

September 13, 2023

Approvals News

Leqembi (lecanemab) Granted Accelerated Approval by the FDA as Alzheimer’s Disease Treatment

January 12, 2023

Blogs

Air Protein Makes Meat out of Thin Air + How Jelly Drops Boosts Water Consumption – Xtalks Food Podcast Ep. 59

May 5, 2022

Blogs

Study Shows Exercise Can Maintain Cognitive Health in Elderly + Abbott’s New Cardiac Mapping System – Xtalks Life Science Podcast Ep. 44

January 19, 2022

Life Science News

Study Shows Exercise Can Strengthen Neural Connections in the Aging Brain to Maintain Cognitive Health

January 13, 2022

Diagnostics News

New Study Shows Diadem’s AlzoSure Alzheimer’s Blood Test Can Predict Disease Years Before Diagnosis

September 2, 2021

Blogs

AAIC 2021: Best Practices for Remote Cognitive Assessments for Alzheimer’s Patients During COVID-19

August 20, 2021

Healthcare News

Patients with Dementia More Likely to Die From COVID-19, Regardless of Living in Long-Term Care

February 9, 2021

Biotech News

Will Wearables Be the New Way to Detect Early Signs of Alzheimer’s?

February 14, 2020

Life Science News

Looking Past the Amyloid-Beta Hypothesis Could Ring in a New Era of Alzheimer’s Research

February 9, 2018

Dementia

In Alzheimer’s Dementia, Should EEG Be Used as a Functional Biomarker of Target Engagement and Organizational Change When Evaluating Treatment Efficacy?

How Are Blood-Based Biomarkers Reshaping Alzheimer’s Disease Diagnostics and Treatment?

Brain Awareness Week 2024: A Spotlight on Brain Health and New Treatments for Neurological Diseases

Biogen Shelves Contentious Alzheimer’s Drug Aduhelm

BrainSee AI-Powered Dementia Test Receives FDA Approval

Cognitive and Neuropsychiatric Disorders Drug Development, Featuring Dr. Adam Kaplin, Cofounder, President, CSO, MIRA Pharmaceuticals – Xtalks Life Science Podcast Ep. 141

Insights into New Alzheimer’s Treatments: Treating Agitation and First THC-Based Therapeutic in Trials — Interview with IGC’s Ram Mukunda and Claudia Grimaldi – Xtalks Life Science Podcast Ep. 127

Leqembi (lecanemab) Granted Accelerated Approval by the FDA as Alzheimer’s Disease Treatment

Air Protein Makes Meat out of Thin Air + How Jelly Drops Boosts Water Consumption – Xtalks Food Podcast Ep. 59

Study Shows Exercise Can Maintain Cognitive Health in Elderly + Abbott’s New Cardiac Mapping System – Xtalks Life Science Podcast Ep. 44

Study Shows Exercise Can Strengthen Neural Connections in the Aging Brain to Maintain Cognitive Health

New Study Shows Diadem’s AlzoSure Alzheimer’s Blood Test Can Predict Disease Years Before Diagnosis

AAIC 2021: Best Practices for Remote Cognitive Assessments for Alzheimer’s Patients During COVID-19

Patients with Dementia More Likely to Die From COVID-19, Regardless of Living in Long-Term Care

Will Wearables Be the New Way to Detect Early Signs of Alzheimer’s?

Looking Past the Amyloid-Beta Hypothesis Could Ring in a New Era of Alzheimer’s Research

To create an account, you will need to agree to the privacy policy and terms of use by clicking the agree button at the bottom of this form.

Privacy Policy

In Alzheimer’s Dementia, Should EEG Be Used as a Functional Biomarker of Target Engagement and Organizational Change When Evaluating Treatment Efficacy?

How Are Blood-Based Biomarkers Reshaping Alzheimer’s Disease Diagnostics and Treatment?

Brain Awareness Week 2024: A Spotlight on Brain Health and New Treatments for Neurological Diseases

Biogen Shelves Contentious Alzheimer’s Drug Aduhelm

BrainSee AI-Powered Dementia Test Receives FDA Approval

Cognitive and Neuropsychiatric Disorders Drug Development, Featuring Dr. Adam Kaplin, Cofounder, President, CSO, MIRA Pharmaceuticals – Xtalks Life Science Podcast Ep. 141

Insights into New Alzheimer’s Treatments: Treating Agitation and First THC-Based Therapeutic in Trials — Interview with IGC’s Ram Mukunda and Claudia Grimaldi – Xtalks Life Science Podcast Ep. 127

Leqembi (lecanemab) Granted Accelerated Approval by the FDA as Alzheimer’s Disease Treatment

Air Protein Makes Meat out of Thin Air + How Jelly Drops Boosts Water Consumption – Xtalks Food Podcast Ep. 59

Study Shows Exercise Can Maintain Cognitive Health in Elderly + Abbott’s New Cardiac Mapping System – Xtalks Life Science Podcast Ep. 44

Study Shows Exercise Can Strengthen Neural Connections in the Aging Brain to Maintain Cognitive Health

New Study Shows Diadem’s AlzoSure Alzheimer’s Blood Test Can Predict Disease Years Before Diagnosis

AAIC 2021: Best Practices for Remote Cognitive Assessments for Alzheimer’s Patients During COVID-19

Patients with Dementia More Likely to Die From COVID-19, Regardless of Living in Long-Term Care

Will Wearables Be the New Way to Detect Early Signs of Alzheimer’s?

Looking Past the Amyloid-Beta Hypothesis Could Ring in a New Era of Alzheimer’s Research

Sign up for our newsletters and receive webinars, vitals and updates for your topic of choice.

To create an account, you will need to agree to the privacy policy and terms of use by clicking the agree button at the bottom of this form.

Privacy Policy